WallStreetZenWallStreetZen

NASDAQ: CASI
Casi Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for CASI

Based on 1 analyst offering 12 month price targets for Casi Pharmaceuticals Inc.
Min Forecast
$12.00+300%
Avg Forecast
$12.00+300%
Max Forecast
$12.00+300%

Should I buy or sell CASI stock?

Based on 1 analyst offering ratings for Casi Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CASI stock forecasts and price targets.

CASI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-15

1 of 1

Forecast return on equity

Is CASI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is CASI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CASI revenue forecast

What is CASI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$59.2M+40.07%
Avg 2 year Forecast
$110.4M+161.22%
Avg 3 year Forecast
$140.4M+232.17%
CASI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CASI revenue growth forecast

How is CASI forecast to perform vs Biotechnology companies and vs the US market?
Company
50.45%
Industry
38.94%
Market
10.52%
CASI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CASI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CASI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CASI$3.00$12.00+300.00%Buy
NKGN$1.80N/AN/A
ICCC$5.29N/AN/A
IPA$1.57$7.00+345.86%Buy
LEXX$3.71$12.00+223.45%Strong Buy

Casi Pharmaceuticals Stock Forecast FAQ

Is Casi Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CASI) stock is to Buy CASI stock.

Out of 1 analyst, 0 (0%) are recommending CASI as a Strong Buy, 1 (100%) are recommending CASI as a Buy, 0 (0%) are recommending CASI as a Hold, 0 (0%) are recommending CASI as a Sell, and 0 (0%) are recommending CASI as a Strong Sell.

If you're new to stock investing, here's how to buy Casi Pharmaceuticals stock.

What is CASI's revenue growth forecast for 2024-2026?

(NASDAQ: CASI) Casi Pharmaceuticals's forecast annual revenue growth rate of 50.45% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Casi Pharmaceuticals's revenue in 2024 is $42,264,000.On average, 1 Wall Street analysts forecast CASI's revenue for 2024 to be $791,987,960, with the lowest CASI revenue forecast at $791,987,960, and the highest CASI revenue forecast at $791,987,960. On average, 1 Wall Street analysts forecast CASI's revenue for 2025 to be $1,476,950,520, with the lowest CASI revenue forecast at $1,476,950,520, and the highest CASI revenue forecast at $1,476,950,520.

In 2026, CASI is forecast to generate $1,878,161,988 in revenue, with the lowest revenue forecast at $1,878,161,988 and the highest revenue forecast at $1,878,161,988.

What is CASI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CASI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CASI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CASI price target, the average CASI price target is $12.00, with the highest CASI stock price forecast at $12.00 and the lowest CASI stock price forecast at $12.00.

The Wall Street analyst predicted that Casi Pharmaceuticals's share price could reach $12.00 by Nov 15, 2024. The average Casi Pharmaceuticals stock price prediction forecasts a potential upside of 300% from the current CASI share price of $3.00.

What is CASI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CASI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.